Mouse anti-Zebrafish RYR1b
- 1.00 Dollar US$
- Published date: April 23, 2026
-
- Shirley, New York, United States
Clonality: Monoclonal
Host: Mouse
Species reactivity.: Zebrafish
Form: Product is supplied as a powder obtained from lyophilization of purified antibody in 1X PBS, aliquot using ddH2O. Reconstitute the antibody with sterile water to a final concentration of 1 mg/ml.
Storage Temp.: −20°C
https://zebrafish.creative-biogene.com/mouse-anti-zebrafish-ryr1b-3494-3524aa-5h12-h2-e3-item-44523-478482.html
0 votes
0 votes
Useful information
- Avoid scams by acting locally or paying with PayPal
- Never pay with Western Union, Moneygram or other anonymous payment services
- Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
- This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"
Related listings
-
CRISPRa Stable Cell Line-HEK293
Molecular Biology Shirley (New York) March 25, 2026 1.00 Dollar US$This cell product is derived from HEK293 cells which has been transduced by lentiviruses containing dCas9-VP64 sequence and MS2-P65-HSF1. Gene transcription will be activated in the presence of sgRNA. The cell line is widely used in library screening...
-
Gene Editing in Primary T Cells
Molecular Biology New York (New York) March 25, 2026 1.00 Dollar US$Creative Biogene CRISPR/Cas9 Platform provides comprehensive gene editing services for various cell lines, especially for primary T cells. With years of experience, our talented scientists have established an efficient assay to edit genome in T cells...
-
Firefly Luciferase circRNA
Molecular Biology Shirley (New York) February 12, 2026 1.00 Dollar US$Firefly Luciferase circRNA will express a luciferase protein, originally isolated from the firefly, Photinus pyralis. It emits bioluminescence in the presence of the substrate, luciferin. Firefly Luciferase circRNA is therefore ideal for monitoring a...

Loading


